Jenna Anderson is the CEO and Co-Founder of Kihealth, a precision diagnostics company transforming healthcare through molecular diagnostics and AI-driven disease interception. She leads the company’s vision to move medicine beyond detecting disease after symptoms appear and toward identifying biological changes at their earliest stages, enabling more personalized, proactive care.
With more than 20 years of experience building and scaling healthcare organizations, Jenna has led growth across digital health, medical technology, diagnostics, and consumer health. Prior to founding Kihealth, she served as President and CEO of AccessElite, where she drove more than 10-fold revenue growth while maintaining exceptional client retention. She also co-founded Soft Health Technologies, successfully launching innovative healthcare products into national retail channels, and previously held executive leadership roles in healthcare marketing and commercialization.
Under Jenna’s leadership, Kihealth has developed a CLIA-certified molecular diagnostics platform focused on early disease detection across diabetes, gut health, inflammation, longevity, and other chronic diseases. The company has earned national recognition, including winning the 2025 American Diabetes Association Innovation Challenge and the KidsX People’s Choice Award for pediatric innovation.
Jenna is passionate about translating cutting-edge science into accessible healthcare solutions that improve patient outcomes while reducing the long-term burden of chronic disease. She is a frequent speaker on precision medicine, preventive healthcare, molecular diagnostics, and the future of disease interception. Jenna holds a Bachelor of Science degree in Public Relations and Business from the University of Florida.
